Status:
COMPLETED
Lidocaine VS Hemodynamic, Metabolic and Hormonal Response
Lead Sponsor:
Medical University of Warsaw
Conditions:
Hemodynamic Response
Acute Appendicitis
Eligibility:
All Genders
18-18 years
Phase:
PHASE4
Brief Summary
Intravenous lidocaine - a potent local anesthetic with analgesic and anti- inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and...
Detailed Description
Laryngoscopy and endotracheal intubation are associated with noxious stimulation. Exacerbated circulatory system response may present as hypertension or arrhythmias including cardiac arrest. A sudden ...
Eligibility Criteria
Inclusion
- ASA physical status class 1E, 2E, 3E;
- Patients undergoing laparoscopic appendectomy.
Exclusion
- Allergy to local anesthetics or contraindications for the use of lidocaine;
- ASA physical status class 4E or higher;
- Severe cardiovascular disease;
- Preoperative bradycardia;
- Preoperative atrioventricular block;
- Renal failure;
- Chronic treatment with analgesics;
- Legal guardians' refusal.
Key Trial Info
Start Date :
March 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2023
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT05238506
Start Date
March 12 2022
End Date
August 8 2023
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic Centre of Medical University of Warsaw
Warsaw, Poland, 02-091